Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$79,676,132
-$1,671,490 QoQ
Shares Held
508,398
-4.5% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#43
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. NVS ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,996,669 | $3,594,294,994 | |
| 2 | JNJ |
Johnson & Johnson
|
13,401,691 | $3,403,627,461 | |
| 3 | ABBV |
AbbVie Inc.
|
11,519,507 | $2,898,768,740 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,387,435 | $2,234,285,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,670,064 | $1,536,729,084 | |
| 6 | AZN |
Astrazeneca PLC
|
6,095,430 | $1,155,815,432 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,618,082 | $962,468,477 | |
| 8 | AMGN |
Amgen Inc
|
1,897,321 | $687,057,877 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $79,676,132 | 508,398 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $81,347,622 | 532,554 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $78,547,571 | 569,722 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $74,975,898 | 584,653 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $76,373,160 | 631,131 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $43,153,237 | 387,094 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $34,152,207 | 350,963 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $48,863,715 | 424,828 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $47,659,372 | 447,674 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $41,549,596 | 429,542 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $36,825,070 | 364,713 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $38,406,209 | 377,049 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $42,723,980 | 423,387 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $38,065,460 | 413,755 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $51,555,902 | 568,297 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $49,002,657 | 644,687 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $60,082,232 | 710,780 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $129,610,872 | 1,477,047 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $117,912,794 | 1,348,037 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $115,717,717 | 1,414,988 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $157,734,524 | 1,728,787 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $147,467,359 | 1,725,168 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $165,549,952 | 1,753,150 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $96,986,660 | 1,115,302 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $102,084,300 | 1,168,815 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $99,501,895 | 1,206,815 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||